Sirtuin 7 plays an oncogenic role in human osteosarcoma via downregulating CDC4 expression

Area of Science:

• Oncology
• Molecular Biology
• Gene Regulation

Background:

• The role of Sirtuin 7 (SIRT7) in cancer remains controversial, with varying functions across different cancer types.
• The specific involvement of SIRT7 in osteosarcoma progression is not yet understood.

Purpose of the Study:

• To investigate SIRT7 expression levels in osteosarcoma.
• To explore the biological functions of SIRT7 in osteosarcoma cell processes.
• To elucidate the underlying molecular mechanisms of SIRT7 action in osteosarcoma.

Main Methods:

• Quantitative analysis of SIRT7 expression in osteosarcoma tissues and cell lines.
• Functional assays including proliferation, migration, invasion, tumor formation, and metastasis assays.
• Mechanistic studies involving histone modification (H3K18ac) and gene transcription (CDC4).

Main Results:

• SIRT7 expression is significantly elevated in osteosarcoma tissues and cell lines compared to non-tumor controls.
• Higher SIRT7 levels correlate with a poorer prognosis in osteosarcoma patients.
• SIRT7 knockdown inhibits osteosarcoma cell proliferation, migration, invasion, tumor formation, and metastasis.
• SIRT7 promotes osteosarcoma progression by downregulating H3K18ac and inhibiting CDC4 transcription.
• Silencing CDC4 partially reverses the inhibitory effects of SIRT7 knockdown.

Conclusions:

• SIRT7 acts as an oncoprotein in osteosarcoma, promoting tumor cell proliferation, migration, and invasion.
• SIRT7 exerts its oncogenic function by targeting CDC4 transcription via H3K18ac modification.
• SIRT7 represents a potential therapeutic target for osteosarcoma treatment.